Table 1.
SNARE | Association with DRMs (%) |
---|---|
Syntaxin 1 | 0% in P2 from homogenized rat brain (Hering et al. 2003); 0% in pancreatic β cells (Ohara-Imaizumi et al. 2004); 0% and 22% in neuroendocrine cells (Lang et al. 2001; Chamberlain et al. 2001), < 10% in synaptosomes from rat brain (Gil et al. 2005) |
Syntaxin 2 | 0% in mast cells (Pombo et al. 2003); 15% in alveolar epithelial cells (Chintagari et al. 2006) |
Syntaxin 3 | > 50% in mast cells (Pombo et al. 2003; for epithelial cells see also Lafont et al. 1999) |
Syntaxin 4 | < 10% in endothelial cell membranes and macrophages (Predescu et al. 2005; Kay et al. 2006); approx. 35% in adipocytes (Chamberlain & Gould, 2002); less than 20% and 50% in mast cells (Puri & Roche, 2006; Pombo et al. 2003) |
SNAP-25 | 0%, 20% and 24% in neuroendocrine cells (Lang et al. 2001; Chamberlain et al. 2001; Salaun et al. 2005b); 20% in synaptosomes from rat brain (Gil et al. 2005) |
SNAP-23 | < 10% in endothelial cell membranes (Predescu et al. 2005); 31% in alveolar epithelial cells (Chintagari et al. 2006); approx. 50% in macrophages (Kay et al. 2006); 54% in neuroendocrine cells (Salaun et al. 2005b); 50 and 70% in mast cells (Pombo et al. 2003; Puri & Roche, 2006); > 70% in adipocytes (Chamberlain & Gould, 2002) |
Synaptobrevin/VAMP2 | 5–24% in neuroendocrine cells (Chamberlain et al. 2001); < 10% in synaptosomes from rat brain (Gil et al. 2005); approx. 20% in mast cells (Puri & Roche, 2006); 22% in alveolar epithelial cells (Chintagari et al. 2006); 36% in adipocytes (Chamberlain & Gould, 2002); 70–80% in macrophages (Kay et al. 2006) |
Cellubrevin/VAMP3 | 20–30% in macrophages (Kay et al. 2006) |
Cell solubilization was performed using Triton X-100 at concentrations ranging from 0.1 to 1%. In the studies by Lang et al. (2001) and Hering et al. (2003) detergent was included in the density gradient steps.